Zhitong Finance App News, Kaituo Pharmaceutical-B (09939.HK) announced that its self-developed long-term safety clinical trial (“this long-term safety clinical trial”) for 1.0% treatment of androgen alopecia (“AGA” or “alopecia”) has been followed up with all subjects, showing good safety.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Kaituo Pharmaceutical-B (09939.HK) announced that its self-developed long-term safety clinical trial (“this long-term safety clinical trial”) for 1.0% treatment of androgen alopecia (“AGA” or “alopecia”) has been followed up with all subjects, showing good safety.